AbbVie Adds Another Alzheimer’s Prospect With $1.4B Aliada Therapeutics Acquisition
Alzheimer’s disease medicines commercialized in the past two years validated amyloid beta as a drug target, but these antibody therapies ...
Thursday, January 2, 2025
Tag: Therapeutics
iTeos Therapeutics: ESMO Data Showing Signs Of A Real Win For TIGIT
Justin Lambert/DigitalVision via Getty ImagesTopline Summary and Update iTeos Therapeutics (NASDAQ:ITOS) is an immunotherapy-focused biotech working on a molecule targeting ...
Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug
Rapport Therapeutics, a young biotech company with technology from the labs of Johnson & Johnson, is now preparing to enter ...
Considerations in payer coverage of digital therapeutics
The Digital Therapeutics Alliance defines a digital therapeutic (DTx) as “evidence-based therapeutic interventions that are ...
C4 Therapeutics’ TORPEDO Platform Is Promising, But Its Valuation Remains Stretched
Motion Loop/iStock via Getty Images C4 Therapeutics, Inc. (NASDAQ:CCCC) pioneered targeted protein degradation with its TORPEDO platform to design molecules ...
Sarepta Therapeutics: Navigating Elevidys Towards FDA Approval
beast01 At a Glance Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has "closed the gap" following my last update and "Buy" recommendation in ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.